A stable latent reservoir for HIV-1 in resting CD4 + T cells is the principal barrier to a cure 1-3 . Curative strategies that target the reservoir are being tested 4,5 and require accurate, scalable reservoir assays. The reservoir was defined with quantitative viral outgrowth assays for cells that release infectious virus after one round of T cell activation 1 . However, these quantitative outgrowth assays and newer assays for cells that produce viral RNA after activation 6 may underestimate the reservoir size because one round of activation does not induce all proviruses 7 . Many studies rely on simple assays based on polymerase chain reaction to detect proviral DNA regardless of transcriptional status, but the clinical relevance of these assays is unclear, as the vast majority of proviruses are defective 7-9 . Here we describe a more accurate method of measuring the HIV-1 reservoir that separately quantifies intact and defective proviruses. We show that the dynamics of cells that carry intact and defective proviruses are different in vitro and in vivo. These findings have implications for targeting the intact proviruses that are a barrier to curing HIV infection.
efficacy of a cure intervention causing a selective one log reduction in intact proviruses may be inapparent (Fig. 1h ).
Interrogating individual proviruses simultaneously at several positions could differentiate intact from defective proviruses. Analysis of nFGS data revealed that strategically placed amplicons in the packaging signal (Ψ) and env regions could jointly identify more than 90% of deleted proviruses as defective ( Fig. 2a ). Hypermutated proviruses must also be identified ( Fig. 1a ). Seventy-three per cent of these have mutations in the GG→AG context (Extended Data Fig. 1a ). Most also have GA→AA mutations. Only 27% of hypermutated proviruses had only GA→AA mutations, and most of these also had deletions (Extended Data Fig. 1a ). Therefore, we focused on GG→AG hypermutation. We identified a conserved region in the Rev-response element (RRE) with adjacent consensus sites (TGGG) for the responsible enzyme, APOBEC3G 10 (Fig. 2b-e ). Of the sequences with GG→AG hypermutation, 97% had one or more mutations in this region (Fig. 2c, e ), with 13 distinct patterns ( Fig. 2f ). Using mutant plasmids carrying each pattern, we developed allelic discrimination probes (Extended Data Fig. 1b ) that correctly identify 95% of hypermutated sequences as defective (Fig. 2f) .
These analyses allowed design of a droplet digital PCR (ddPCR) method that distinguishes most deleted and/or hypermutated proviruses from intact proviruses using two amplicons and hypermutation discrimination probes ( Fig. 3a, b ). Genomic DNA (gDNA) is isolated using an optimized method to minimize DNA shearing between targeted regions (see below) and partitioned into nanodroplets such that individual droplets rarely contain more than one provirus (P = 0.00416). Proviruses within droplets are analysed simultaneously at the Ψ and env regions via multiplex PCR, with the env PCR also discriminating hypermutated proviruses. Intact proviruses give amplification at both regions ( Fig. 3a, b ). Intact proviruses per 10 6 cells are calculated using separate amplification of a cellular gene (RPP30) after correction for DNA shearing.
The ability of this intact proviral DNA assay (IPDA) to distinguish intact and defective proviruses was verified using plasmid controls that represent proviruses with different defects. These templates gave positive droplets in the expected quadrants: quadrant 1 (Q1) for 3′ deletion and/or hypermutation and Q4 for 5′ deletion (Extended Data Fig. 2 ). Cultured clonal populations of infected patient cells also give single quadrant patterns (see below). By contrast, uncultured polyclonal patient CD4 + T cell populations gave droplets in all four quadrants, allowing separate quantification of intact and defective proviruses (Fig. 3c) .
Validation of the IPDA is described in Extended Data Figs. 3 and 4. DNA shearing is essential for droplet formation but artificially reduces Letter reSeArCH double-positive (Q2) droplets while increasing Q1 and Q4 droplets. To control for shearing, two regions of a cellular gene (RPP30) with the same spacing as the Ψ and env amplicons are amplified in a separate multiplex ddPCR on each sample. This gives a DNA shearing index (DSI) to correct raw HIV-1 ddPCR results (see Methods). To validate this approach, DNA from JLat cells 11 , which contain a single provirus, was subjected to different amounts of shearing and analysed by ddPCR for HIV-1 and RPP30. At all levels of shearing, DSI was similar for HIV-1 and RPP30. Thus, RPP30 shearing can be used to correct for HIV-1 shearing (Fig. 3d) . At all levels of shearing, corrected results were close to the expected values of one copy per cell for HIV-1 ( Fig. 3e ) and four copies per cell for RPP30 (JLat cells are tetraploid for RPP30). With correction for shearing, the IPDA gives highly accurate discrimination between molecularly defined standards representing intact and defective proviruses (Extended Data Fig. 5 ). In acute in vitro infections, high molecular mass DNA from productively infected CD4 + T cells showed a substantial fraction of intact proviruses as assessed by IPDA and confirmed by nFGS (Extended Data Fig. 6 ). Thus, the assay can reliably quantify intact proviruses in most DNA samples after correction for shearing.
Using samples of only 5 × 10 6 cells, we measured intact and defective proviruses in 62 infected individuals who had suppression of viraemia on antiretroviral therapy (ART) (n = 57) or 'elite' control of HIV-1 without ART (n = 5) (Supplementary Table 3 ). The median DSI was 0.32 (interquartile range ± 0.07; Extended Data Fig. 7 ), well within the range for which accurate correction is possible. Intact proviruses were rare (approximately 100 per 10 6 resting CD4 + T cells) and greatly outnumbered by defective proviruses (Fig. 3f ). These results provide the first demonstration, to our knowledge, using a method not requiring long-distance PCR that the proviral landscape is dominated by defective proviruses. We found strong correlations between IPDA and quantitative viral outgrowth assay (QVOA) measurements on the same Letter reSeArCH samples (r = 0.48, P = 0.003, n = 35, Fig. 3g ), even though the fraction of intact proviruses induced by a single round of T cell activation in the QVOA is small and variable between individuals ( Fig. 3h ).
Using nFGS data, we compared the IPDA with the widely used gag PCR with respect to desired assay characteristics. IPDA detects a larger fraction of proviruses ( Fig. 3i ) and separately enumerates intact and two class of defective proviruses. More importantly, the IPDA excludes 97% of proviruses with defects detectable by nFGS ( Fig. 3i ). The fraction of defective proviruses excluded by standard PCR assays is much lower and almost zero for Alu PCR assays. It is only 30% for gag PCR. Most proviruses (approximately 70%) classified as intact by IPDA lack defects detectable by nFGS. By contrast, this value is less than 10% for gag PCR (Fig. 3i ). Thus, the IPDA provides a scalable alternative that is much more selective for intact proviruses. Most defects missed by IPDA are small deletions not overlapping IPDA amplicons. In addition, although nFGS data used to design the assay covers 97.6% of the non-redundant HIV-1 sequence, small deletions in the remaining portion of the genome may be present in some proviruses. The assay was designed for use in treated patients and does not distinguish integrated proviruses from unintegrated linear or circular forms. These are rare in patients on longterm ART 8 . Further sequence data and improved ddPCR technology may allow even greater selectivity for intact proviruses. Importantly, selective intervention-induced reductions in intact proviruses would be apparent with the current IPDA but not with standard assays (Fig. 3i ).
The latent reservoir measured by QVOA undergoes slow decay (t 1/2 = 44 months) 12, 13 . Intact proviruses measured by IPDA show similar decay (Fig. 4a, b ). For most patients, intact proviruses declined with a t 1/2 of approximately 44 months. Some patients showed even slower decay (t 1/2 = 100-300 months), and for 3 out of 14 patients, there was no decay (Fig. 4b, c ). Thus, the IPDA can measure changes consistent with known reservoir dynamics and possibly define subpopulations with slower decay.
The dynamics of defective proviruses in the same patients showed greater variability, with increases over time in some patients ( Fig. 4a , c, Extended Data Fig. 8 ). Although the mean decay slopes did not differ, the standard deviations of decay slopes were much greater for defective proviruses (Extended Data Fig. 9 ), complicating interpretation of assays dominated by defective forms. Increases in infected cell frequency can reflect the proliferation of infected cells [14] [15] [16] [17] [18] [19] . Although the IPDA cannot demonstrate the presence of expanded clones, it can detect increases in infected cell frequency due to clonal expansion. We asked whether the differential dynamics of cells with intact and defective proviruses could be due to uneven distribution in subsets of memory CD4 + T cells 20 with different proliferative potential. Intact and defective proviruses were found in expected ratios in central, transitional and effector memory subsets ( Fig. 4d ). We then asked whether intact and defective proviruses imposed different constraints on proliferation. We used the IPDA to track individual infected cells from treated patients after in vitro stimulation with anti-CD3/28 ( Fig. 4e ). Microcultures seeded with around one infected cell per well were subjected to four rounds of stimulation in the presence of antiretroviral drugs. Analysis of more than 1,700 microcultures showed that positive droplets were detected in only one out of three possible quadrants for most positive wells, as expected for cultures initiated with a single infected cell and cultured with antiretroviral drugs (Fig. 4e ). Most (97.6%) proviruses were defective ( Fig. 4f ). Importantly, the IPDA also counts proviruses in each well, allowing the direct quantification of infected cell proliferation. Some cells carrying defective proviruses showed enormous clonal expansion (1,000-fold), whereas cells with intact proviruses were rarely detected and showed little proliferation ( Fig. 4f ). Despite fewer wells with intact Optimal discrimination between intact and deleted sequences is obtained with a 5′ amplicon in the Ψ region and a 3′ amplicon in env. Ψ is the site of frequent small deletions and is included in larger 5′ deletions. Analysis is based on 431 independent near full genome sequences in the database including 258 that contain mapped deletions. Inclusion of an additional 474 sequences from treated patients did not change optimal positions. b, Nucleotide conservation across the env gene based on US clade B sequences in the Los Alamos HIV Sequence Database is plotted as the percentage of sequences matching the consensus sequence at each nucleotide. Shaded area is expanded in Fig. 2d . c, GG→AG hypermutation across the env gene. The percentage of hypermutated proviruses that contain one or more G→A mutations within a given APOBEC3G consensus site is plotted as a function of site position. Shaded area is expanded in Fig. 2e . d, Sequence conservation of a region in the RRE containing two APOBEC3G consensus sites. Primer (arrows) and probe (box) positions for the env amplicon are shown. e, Fraction of hypermutated proviruses with G→A mutations in the probe-binding region (shaded). f, Hypermutation patterns at the env probe-binding site.
The prevalence of 13 observed patterns is indicated in the bar graph on the left and in the 'percentage' column. Mutations in the APOBEC3G consensus sites (underlined) are indicated in red. Analysis is based on 93 independent hypermutated env sequences from 18 treated patients. Site-directed mutagenesis was used to modify NL4-3 or a patient-derived proviral construct to generate plasmids containing each pattern. The 'amplified' column indicates that only 5% of hypermutated sequences were amplified by the probe combinations developed to identify intact sequences.
provirues, differences in the mean number of intact and defective proviruses per well remained highly significant (P = 0.0029 to P < 0.0001 by unpaired t-test with Welch's correction for intact proviruses versus proviruses with hypermutation and/or 3′ deletions). These differences are minimal estimates because the fraction of positive microcultures with intact proviruses was lower than expected based on IPDA analysis of the starting population (3.3% versus 7.5%), indicating that some cells with intact proviruses die. These results demonstrate a proliferative defect in response to repetitive in vitro T cell receptor stimulation for cells carrying intact proviruses and show that the IPDA can be a useful initial high-throughput screening tool for mechanistic studies with the caveat that not all Q2 droplets represent intact proviruses ( Fig. 3i ). Analysis of proviral integration sites 14, 15, 21 of expanded clones demonstrated that the cultures were clonal and that integration into genes with cancer association was not required for proliferation ( Fig. 4f , Supplementary Table 4 ). Instead, proliferative potential is related to proviral defects. nFGS confirmed the clonal nature of the proviruses in each well and demonstrated directly that the IPDA correctly identifies the presence and nature of defects in proviruses ( Fig. 4g ). Of 12 clonally expanded defective proviruses sequenced, 9 were defective in all HIV-1 ORFs, and none was fully competent for the expression of Tat or of Vif, Vpr, Vpu, Env or Nef. Low or absent expression of these genes would allow stimulated cells to escape viral cytopathic effects that could limit proliferation 22, 23 .
The failure of cells carrying intact proviruses to expand after repetitive in vitro T cell receptor stimulation provides insights into the mechanisms that drive in vivo clonal expansion [16] [17] [18] 24 and into cure strategies that involve T cell activation. The reservoir of intact proviruses undergoes slow decay in vivo, as shown here and previously 12, 13 . Thus, observed clonal expansions [14] [15] [16] [17] [18] [19] must be more than offset by the death of infected cells. Strong T cell receptor stimulation may induce viral gene expression and cell death or impaired proliferation as shown in our in vitro experiments. Clonal expansion in vivo may be driven by stimuli including homeostatic cytokines that allow proliferation without virus production 19, 20 . Table 3 for patient characteristics. Polymorphisms precluding amplification with either primer/probe set were not observed in this cohort and would require triage primer/probe sets incorporating rare polymorphisms. g, Correlation between infected cell frequencies measured by QVOA and IPDA on the same samples of CD4 + T cells from treated patients (n = 36). IUPM, infectious units per million cells. h, IPDA/QVOA ratios for samples from Fig. 3g . Horizontal bars indicate geometric mean and 95% confidence interval. i, Bioinformatic comparison of standard gag PCR and IPDA with respect to the percentage of proviruses amplified, percentage of defective proviruses excluded, percentage of amplified proviruses that are intact, and percentage loss in assay signal after a selective tenfold reduction in intact proviruses. Fn, fraction. All fractions expressed as percentages. See Fig. 1f -h for details.
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Our results show that the small subset of proviruses with the potential to cause viral rebound show different dynamics than the vast excess of defective proviruses captured in standard PCR assays, emphasizing the importance of direct measurement of intact proviruses. The availability of a scalable assay for intact proviruses should accelerate cure research.
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MEthodS
Study participants. Characteristics of study participants are given in Supplementary Table 3 . The Johns Hopkins Institutional Review Board and the UCSF Committee on Human Research approved this study. All participants provided written consent before enrolment. Except where indicated, participants were HIV-1-infected adults on suppressive ART with undetectable plasma HIV-1 RNA levels (<50 copies per ml) for more than 6 months. Chronic phase (CP)treated subjects are defined as subjects starting ART more than 180 days from the estimated date of infection. Acute phase-treated subjects started ART less than 100 days after the estimated date of infection. For longitudinal analysis, additional peripheral blood mononuclear cell (PBMC) samples were obtained from 10 HIV-1infected men followed in the Baltimore-Washington DC centre of the Multicentre AIDS Cohort Study (MACS) 27 who had undetectable plasma HIV RNA (less than 20 copies per ml by Roche Taqman assay) at all semiannual study visits for 5 years or more, with no blips or missed visits. PBMC cryopreserved at visits at least 5 years apart, and viably stored as per MACS protocols, were studied. Characteristics of these 10 men are given in Supplementary Table 3 (CP31-CP49). CD4 + T cell isolation. PBMCs were isolated by density centrifugation using Ficoll-Paque PLUS (GE Healthcare Life Sciences) per the manufacturer's instructions. Untouched total CD4 + T cells were then enriched from PBMCs using negative immunomagnetic selection using the EasySep Human CD4 + T-Cell Enrichment Kit (StemCell Technologies). In some experiments, resting CD4 + T cells (CD4 + , CD69 -, CD25and HLA-DR -) were isolated using a second negative selection step (CD25-Biotin; Anti-Biotin MicroBeads; CD69 MicroBead Kit II; Anti-HLA-DR MicroBeads, all from Miltenyi Biotec). Resting CD4 + T cell purity was consistently greater than 95% as assessed using flow cytometry. Bioinformatic analysis. We constructed an alignment of 431 published 8, 9 fulllength proviral sequences obtained from 28 HIV-1-infected adults by single genome analysis. Of these individuals, 19 started suppressive ART during chronic infection, and 9 started suppressive ART during acute infection. Twenty-four individuals had prolonged suppression of viraemia (>6 months) when studied, and five were viraemic when studied (one individual was studied at two time points, before and after ART). Clinical characteristics of these individuals are given in the relevant publications 8, 9 . The proportion of different types of defects in HIV-1 proviruses varies with the stage of disease at which ART is started and the level of viraemia 8 . For most analyses, we used sequences from patients who initiated ART during chronic infection and who had sustained suppression of viraemia to below 50 copies HIV-1 RNA per ml of plasma for >6 months. These sequences (n = 211) are thus representative of the most common group of infected individuals who would be eligible for cure interventions. The proviral landscape in patients starting ART during acute infection is also dominated by defective sequences, with a higher fraction showing hypermutation 8 . In the analysis of deletions, common length polymorphisms were not included. Terminal deletions preclude integration and are not seen. Internal deletions in the 5′ LTR are not evaluable because the nFGS methods do not capture this region. Hypermutation occurred with or without deletions. For analyses of specific types of defect, we used all sequences in the database with that defect. For example, for analysis of hypermutation, we used all database sequences with hypermutation (n = 100) and additional hypermutated sequences obtained by single genome env sequencing. Hypermutation in the GG or GA context was confirmed using the Hypermut algorithm 28 . Positions of primers for ddPCR analysis were evaluated using a sliding window analysis of two hypothetical 100-base-pair amplicons, scoring for lack of significant overlap (>5%) with mapped deletions in the database sequences with deletions. Optimal discrimination between intact and deleted sequences is obtained with a 5′ amplicon in the Ψ region and a 3′ amplicon in env. Ψ is the site of frequent small deletions and is included in larger 5′ deletions. Sequence conservation was evaluated using separate alignments of US clade B sequences from the Los Alamos HIV sequence database (https://www.hiv.lanl.gov/). IPDA. A variety of experimental conditions were used in the development of the IPDA. The following is an optimized recommended procedure. In general, the IPDA is performed on DNA from 5 × 10 6 CD4 + T cells. Genomic DNA is extracted using the QIAamp DNA Mini Kit (Qiagen) with precautions to avoid excess DNA fragmentation. DNA concentrations are determined using the Qubit3.0 and Qubit dsDNA BR Assay Kit (ThermoFisher Scientific). Quantification of intact, 5′ deleted, and 3′ deleted and/or hypermutated proviruses is carried out using primer/probe combinations optimized for subtype B HIV-1 (Accelevir Diagnostics). The primer/probe mix consists of oligonucleotides for two independent hydrolysis probe reactions that interrogate conserved regions of the HIV-1 genome to discriminate intact from defective proviruses ( Supplementary Table 5 ). HIV-1 reaction A targets the packaging signal (Ψ) that is a frequent site of small deletions and is included in many large deletions in the proviral genome. The Ψ amplicon is positioned at HXB2 coordinates 692-797. This reaction uses forward and reverse primers, as well as a 5′ 6-FAM-labelled hydrolysis probe. Successful amplification of HIV-1 reaction A produces FAM fluorescence in droplets containing Ψ, detectable in channel 1 of the droplet reader. HIV-1 reaction B targets the RRE of the proviral genome, with the amplicon positioned at HXB2 coordinates 7736-7851. This reaction uses forward and reverse primers, as well as two hydrolysis probes: a 5′ VIC-labelled probe specific for wild-type proviral sequences, and a 5′ unlabelled probe specific for APOBEC-3G hypermutated proviral sequences ( Supplementary Fig. 2 ). Successful amplification of HIV-1 reaction B produces a VIC fluorescence in droplets containing a wild-type form of RRE, detectable in channel 2 of the droplet reader, whereas droplets containing a hypermutated form of RRE are not fluorescent.
Droplets containing HIV-1 proviruses are scored as follows. Droplets positive for FAM fluorescence only, which arises from Ψ amplification, score as containing 3′ defective proviruses, with the defect attributable to either APOBEC-3Gmediated hypermutation or 3′ deletion. Droplets positive for VIC fluorescence only, which arises from wild-type RRE amplification, score as containing 5′ defective proviruses, with the defect attributable to 5′ deletion. Droplets positive for both FAM and VIC fluorescence score as containing intact proviruses (Fig. 3a, b) . Double-negative droplets contain no proviruses or rare proviruses (approximately 3.8%) with defects affecting both amplicons.
An important aspect of the quantification of intact proviruses is correction for DNA shearing between amplicons, which artificially reduces Q2 droplets while increasing Q1 and Q4 droplets (Fig. 3b ). This can be done accurately through ddPCR analysis of a host gene, which also provides a measure of input cell number. In principle, any host gene can be used, with two ddPCR amplicons spaced at the same distance as the HIV-1 amplicons described above. As demonstrated in Fig. 3d , e, this approach allows for accurate correction for DNA shearing. Simultaneous quantification of DNA shearing and input human genome equivalents is performed using another aliquot of the same DNA sample. For the studies described here, oligonucleotides for two independent hydrolysis probe reactions that interrogate the human RPP30 gene (chromosome 10: 90,880,081 on GRCh38) were used (Accelevir Diagnostics). In this primer/mix, the total distance between duplex reactions and individual amplicon sizes are equivalent to those of the HIV-1 proviral discrimination reactions described above. Optimal reaction melting temperatures are equivalent for all reactions. Comprehensive oligonucleotide analysis predicted no potential off-target nucleotide binding or amplification (BLASTn) and no self-dimerization, hetero-dimerization, or primer hairpin formation. RPP30 reaction A uses a 5′ 6-FAM-labelled hydrolysis probe, and RPP30 reaction B uses a 5′ HEX-labelled hydrolysis probe. Droplets positive for both 6-FAM and HEX fluorescence score as containing an unsheared RPP30 gene fragment, whereas droplets positive for only a single fluorescence score as containing part of a sheared RPP30 gene fragment. The ratio of dual fluorescent to single fluorescent droplets is used to calculate a DSI, and this index is applied to both genome copy number input reactions and HIV-1 proviral discrimination reactions to correct for experimentally observed DNA shearing.
ddPCR was performed on the Bio-Rad QX200 AutoDG Digital Droplet PCR system using the appropriate manufacturer supplied consumables and the ddPCR Supermix for probes (no dUTPS) (Bio-Rad Laboratories). For HIV-1 proviral discrimination reactions, 700 ng of genomic DNA was analysed in each reaction well. For DNA shearing and copy number reference reactions, 7 ng of genomic DNA was analysed in each reaction well. Multiple replicate wells were performed for each reaction type to ensure consistent quantification, and replicate wells were merged during analysis to increase IPDA dynamic range. The thermal cycling program used for all reactions, with a 2 °C ramp rate, is given in Supplementary  Table 6 . In general, parallel processing and analysis of uninfected donor CD4 + T cells was performed for each IPDA run as a negative control while qualified JLat6.3 genomic DNA was analysed in each IPDA run as a positive control. After correction for DNA shearing, results are expressed as proviral copies per 10 6 CD4 + T cells. Cell lines. The JLat full-length clone (clone 6.3) from E. Verdin was obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH. Cells were authenticated through short tandem repeat analysis and tested negative for mycoplasma. QVOA. The QVOAs were performed as previously described 1, 29 . MOLT-4/CCR5 cells 30 were added on day 2 of the culture and the culture supernatants were examined for the p24 viral capsid protein by ELISA (PerkinElmer) after 14 and 21 days. Results were expressed as infectious units per million cells (IUPM) CD4 + T cells calculated using maximal likelihood as described by previously (IUPMStats 31 ). T cell subset analysis. Resting CD4 + T cells from HIV-1-infected donors on suppressive ART were isolated as described above. To sort resting memory subsets, we incubated cells with FcgR block (BD Pharmingen) for 10 min before staining with a FITC-labelled antibody to CD3 (Biolegend; clone HIT3a), phycoerythrin (PE)-Cy7-labelled antibody to CD4 (Biolegend; clone RPA-T4), allophycocyanin (APC)-labelled antibody to CD45RO (Biolegend; clone UCHL1), BV421-labelled antibody to CD27 (Biolegend; clone O323) and PE-labelled antibody to CCR7 (Biolegend; clone G043H7). Dead cells were excluded using propidium iodide. PE mouse IgG2aκ, BV421 mouse IgG1κ, and APC IgG2aκ isotype antibodies were used in fluorescence-minus-one controls to set sorting gates. Memory cells were distinguished from naive cells by the presence or absence of CD45RO staining, respectively. Central memory cells were distinguished from effector and transitional memory subsets by the presence of CCR7 as described previously 32 . CCR7 − cells were subdivided into effector memory (T EM ) (CD45RO + CCR7 − ) or transitional memory (T TM ) (CD45RO + CCR7 − CD27 + ) cells as described previously 20 . Central, effector and transitional resting memory subsets were sorted using a Beckman Coulter MoFlo XDT Cell sorter. Clonal microcultures. Purified resting CD4 + T cells from HIV-1-infected donors on suppressive ART were analysed for proviral DNA copies using gag quantitative PCR as previously described 33 . The resulting values were corrected for gag − proviruses, and cells were plated at approximately one infected cell per well (2,000-4,000 total resting CD4 + T cells) in 96-well plates. The cells were then stimulated with anti-CD3/CD28 Dynabeads (25 μl per million cells; Thermo Fisher Scientific) in RPMI containing 10% fetal bovine serum and 100 U ml −1 IL-2 (Novartis) for 7 days in the presence of tenofovir disoproxil fumarate (10 μM) and emtricitabine (10 μM). Half of the medium in each well was removed and replaced with fresh medium, anti-CD3/CD28 Dynabeads and antiretroviral drugs weekly for 2-3 weeks. DNA isolation was performed on cells from each well using a Quick-DNA 96 Kit (Zymo Research Corporation). One-quarter of the extracted DNA was analysed by the IPDA to determine the type of provirus and proviral copy number in each well. The remaining DNA was used for integration site analysis and full genome sequencing. Integration site analysis. Integration site analysis was performed using previously described linker ligation method 26, 34, 35 . Sites for which both the 5ʹ and 3ʹ junctions were captured are shown. Cancer associations were determined as previously described 35 . Full genome sequencing. Full genome sequencing was performed at the single molecule level as previously described 8 . Fig. 1 | Analysis of hypermutation. a, Most hypermutated proviruses show both GG→AG and GA→AA patterns of hypermutation. Analysis based on hypermutated full-genome sequences in the database (n = 100). Sequences were analysed for GG→AG and GA→AA patterns using all available sequences for each clone and the Los Alamos Hypermut algorithm 17 . b, Hypermutation discrimination using two probes in the RRE of the env gene. The intact probe hybridizes with a region containing two adjacent APOBEC3G consensus sites (red underline) in intact proviruses. It is labelled with a fluorophore (VIC) and a quencher (Q). Also present in the reaction is a hypermutated probe that lacks the fluorophore and does not bind (arrow) to intact proviral sequences owing to G→A mutations at both APOBEC3G consensus sites.
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Extended Data
Dashed boxes indicate the nucleotide positions of sequence differences between the intact and hypermutated probes. The hypermutated probe preferentially binds to the same region in hypermutated proviruses. It lacks a fluorophore and prevents binding of the fluorophore-labelled intact probe (arrow). Therefore, no fluorescent signal is generated for 95% of hypermutated proviruses (Fig. 2f ). . Plasmid 2G10 is a heavily hypermutated patient-derived sequence with G→A mutations in the probe-binding region of the env amplicon (enlarged region). Plasmid 19B3 has GA point mutations in this region. These G→A mutations (red) occur at two APOBEC3G consensus sites (TGGG, underlined) in this region. These plasmids have been previously described 12, 34 . b-e, IPDA on plasmids representing the indicated defective proviruses showing positive droplets only in the expected quadrants. Fig. 3 | IPDA accuracy, reproducibility and limit of quantification. a, Correlation between expected and IPDA-measured frequencies of intact proviruses per 10 6 cells. Genomic DNA from uninfected donor CD4 + T cells was spiked with JLat6.3 DNA cell equivalents and subjected to a serial fourfold dilution. This material was then analysed by the IPDA, and the IPDA-measured frequencies of intact proviruses per million cells were compared to the expected frequencies (998, 249.5, 62.4, 15.6 and 3.9 intact proviruses per 10 6 CD4 + T cells). This experiment was performed independently three times. The agreement between the expected and IPDA-measured frequencies of intact proviruses was determined using Pearson correlation. b, Reproducibility of the IPDA across independent assay runs. Reproducibility was assessed by determining the coefficient of variation (CV) across three independent assay measurements of genomic DNA from uninfected donor CD4 + T cells spiked with JLat6.3 cell equivalents and subject to serial fourfold dilution, as described in a. Positions of the Ψ (blue) and env (green) IPDA amplicons and of a distinct set of plasmid shearing control (PSC, magenta boxes) amplicons are indicated. Spacing between PSC amplicons is equal to spacing between Ψ and env amplicons. Dotted lines indicate positions of deletions in plasmids carrying previously described 12 defective proviruses E44E11 and 4F12 with 5′ and 3′ deletions, respectively. b, IPDA analysis of the indicated ZraI-cut plasmids representing intact, 5′-deleted and 3′-deleted proviruses. c, Summary of droplet counts for the experiment shown in b. E44E11 and 4F12 give positive droplets only in quadrants 4 and 1 (Q4 and Q1), respectively. For pNL4-3, more than 95% of droplets are in Q2, with the remainder attributable to shearing between the Ψ and env amplicons. d, Analysis of shearing. For IPDA analysis of patient samples, shearing was measured using amplicons in the RPP30 gene ( Fig. 3a, d, e ).
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For plasmid control experiments, shearing of ZraI-cut plasmids was analysed using two sets of amplicons, the Ψ and env IPDA amplicons and the equally spaced PSC amplicons shown in a. ddPCR analysis was done on fresh (D0) maxipreps of pNL4-3 linearized with ZraI at a concentration mimicking patient samples. To assess the effects of higher levels of DNA fragmentation, IPDA analysis was also done on pNL4-3 DNA that had been incubated at 4 °C for 5 days (D5), and on pNL4-3 DNA cut with both ZraI and EcoRI (two cuts). The mean and range of duplicate determinations of the DSI is shown for each set of amplicons.
The DSI was the same for the IPDA and PSC amplicons at three different levels of shearing. The DSI was used to correct the IPDA droplet counts in e. Negative values were set to 0. e, Uncorrected and DSI-corrected IPDA analysis of the intact proviral construct pNL4-3 at different levels of fragmentation. After correction, positive droplets were almost exclusively in Q2 even at higher levels of fragmentation. 
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